We are a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care.

We aim to achieve this patient-centric mission with a focus on developing a portfolio of highly innovative assets, unconstrained by therapeutic area or technology.

Our core operating principle is to make timely, unbiased decisions driven by data and biology. We focus on making the best decisions for each asset without constraints or bias stemming from the needs of other programs in the portfolio.